By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Zambon Group spa 

Via Lillo del Duca
20091 Bresso
Milan    10 - 20091  Italy
Phone: 39-02-665241 Fax: 39-02-66501492 / Tx. 330042


SEARCH JOBS








Company News
Zambon Launches Xadago (Safinamide) In The U.K. For Patients With Mid- To Late-Stage Parkinson’s Disease 5/23/2016 10:05:37 AM
Zambon Launches Xadago (Safinamide) In Denmark And Sweden For Patients With Mid- To Late-Stage Parkinson’s Disease 4/28/2016 9:55:26 AM
Newron Pharma (NWRN) And Partner Zambon Support Parkinson's Disease Awareness Day 2016 4/11/2016 8:20:10 AM
Zambon Launches Xadago (Safinamide) In Belgium For Patients With Mid-To Late Stage Parkinson's Disease 4/4/2016 9:59:55 AM
Zambon And U.S. WorldMeds Partner To Bring Newron Pharmaceuticals (NWRN)’ Parkinson’s Disease Treatment Xadago (Safinamide) To The U.S. 3/17/2016 9:59:20 AM
Zambon Launches Xadago (Safinamide) In Italy For Patients With Mid- To Late-Stage Parkinson’s Disease 2/29/2016 10:42:05 AM
Zambon Launches Xadago (Safinamide) In Spain For Patients With Mid- To Late-Stage Parkinson’s Disease 2/22/2016 2:26:15 PM
Zambon Launches Xadago (Safinamide) In Switzerland For Patients With Parkinson’s Disease 1/12/2016 11:57:08 AM
Newron Pharmaceuticals (NWRN) And Zambon Release: Swissmedic Approves Xadago (Safinamide) For Use In Parkinson’s Disease 11/13/2015 10:14:39 AM
Zambon Launches Xadago (Safinamide) For Patients With Mid- To Late-Stage Parkinson’s Disease In Germany 5/15/2015 9:05:33 AM
12
//-->